Biocon Surges After Syngene Gets Sebi Nod for IPO

Shares of Biocon rose over 2 per cent in early trade on Bombay Stock Exchange (BSE) after Syngene International, research arm of biotechnology major received Securities Exchange Board of India's (Sebi) approval to launch an initial public offer (IPO).

Biocon Surges After Syngene Gets Sebi Nod for IPO

As per the draft papers, Syngene International plans to sell 22 million equity shares, including reservation of up to two million shares for Biocon shareholders, through an offer for sale.

Cheering the development, shares of company surged 2.03 per cent in intra-day trade to quote at Rs 455.95 apiece on the BSE.

In a similar trend, shares of the company gained 2.12 per cent to trade at Rs 456 a piece on National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 26,494.83, down 91.72 points, or 0.34 per cent at 11.11 hours.

Read more about: biocon
Story first published: Tuesday, June 16, 2015, 12:40 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?